ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.738,57
-0,12%
Dow Jones
42.331,76
0,37%
Euro vs US Dollar
1,1167
-0,08%
Bitcoin
65.772,15
0,90%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Pfizer Inc (PFE)

  7. Pfizer Inc (PFE) News

PFE

Pfizer (PFE)

Pfizer Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:PFE
DatumZeitQuelleÜberschriftSymbolFirma
25/09/202423h00Business WirePfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide MarketsNYSE:PFEPfizer Inc
20/09/202414h11Business WirePfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European UnionNYSE:PFEPfizer Inc
17/09/202423h01AllPennyStocks.comTargeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer HopeNYSE:PFEPfizer Inc
17/09/202416h00Business WirePfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with AnalystsNYSE:PFEPfizer Inc
16/09/202419h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/09/202419h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/09/202419h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/09/202419h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/09/202418h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/09/202418h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/09/202418h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/09/202418h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/09/202418h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/09/202418h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/09/202418h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
14/09/202414h45Business WirePfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer CachexiaNYSE:PFEPfizer Inc
14/09/202410h15Business WirePfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung CancerNYSE:PFEPfizer Inc
13/09/202422h49Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NYSE:PFEPfizer Inc
11/09/202412h45Business WirePfizer Highlights Diverse Oncology Portfolio and Combination Approaches at ESMO 2024NYSE:PFEPfizer Inc
04/09/202400h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
04/09/202400h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
04/09/202400h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
28/08/202416h00Business WirePfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare ConferenceNYSE:PFEPfizer Inc
27/08/202412h45Business WirePfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to HealthcareNYSE:PFEPfizer Inc
23/08/202414h20IH Market NewsCruise and Uber Join Forces for Robotaxis, Alibaba Shifts Primary Listing to Hong Kong, Altria Hikes Dividend 4.1%NYSE:PFEPfizer Inc
22/08/202420h15Business WirePfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 VaccineNYSE:PFEPfizer Inc
22/08/202417h17Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NYSE:PFEPfizer Inc
16/08/202421h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/08/202421h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/08/202412h45Business WirePfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of AgeNYSE:PFEPfizer Inc
 Showing the most relevant articles for your search:NYSE:PFE

Kürzlich von Ihnen besucht

COIN
DOGEUSD
Dogecoin
AMEX
SPY
SPDR S&P 500
TG
LHA
Deutsche Lufthansa
CCOM
US30
US 30
AMEX
XLV
Health Care Select Sector
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
FX
EURJPY
Euro vs Yen
DBI
DAX
DAX
NASDAQ
GOOGL
Alphabet
NYSE
KO
Coca Cola
TG
DBK
Deutsche Bank
CCOM
US100
US Tech 100
TG
BAYN
Bayer
NASDAQ
AMZN
Amazon.com
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten